Agenus | الدين





الدين تغيير تاريخ
AbbVie USD 1000K 70.48B 2025-09
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 54.59B 1.62B 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Celldex Therapeutics USD 2.62M 410K 2025-09
CSL USD 11.96B 219M 2024-12
Dynavax Technologies USD 285.5M 24.99M 2025-06
Eli Lilly USD 42.51B 2.6B 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
Incyte USD 41.27M 1.14M 2025-09
Intrexon USD 0 13.82M 2024-06
J&J USD 45.8B 4.97B 2025-09
Jiangsu Hengrui CNY 91.43M 17.24M 2025-06
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
MacroGenics USD 37.01M 238K 2025-09
Merck EUR 9.4B 704M 2025-06
Merck USD 41.37B 5.97B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 60.85B 78M 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 50.65M 145K 2025-06


Agenus الدين - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.